Reven Announces the Appointment of Eminent Physician-Scientist Fatih M. Uckun, M.D., Ph.D., Internationally Recognized for His Seminal Contributions to Oncology, Immunology and Immunity, as Its Chief Medical Officer and Chief Scientific Officer

July 2, 2020

OA Online

GOLDEN, Colo.–(BUSINESS WIRE)–Jul 1, 2020–

Reven Holdings, Inc. (“Reven”), a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment platforms for cancer, viral illnesses—including COVID-19—and inflammatory disorders, today announced the appointment of Dr. Fatih M. Uckun as its Chief Medical Officer and Chief Scientific Officer… Read more…